RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages-Reference-Cited by-同舟云学术

RIP1 kinase activity promotes steatohepatitis through mediating cell death and inflammation in macrophages

Published:2020-11-18 Issue:4 Volume:28 Page:1418-1433
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Tao Liang,Yi Yuguo,Chen Yuxin,Zhang Haibing^ORCID,Orning Pontus,Lien Egil,Jie Jiapeng,Zhang Weigao,Xu Qian,Li Yang,Ding Zhao,Wu Chao,Ding Qiurong^ORCID,Wang Junsong^ORCID,Zhang Jianfa,Weng Dan

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/s41418-020-00668-w.pdf

Reference55 articles.

1. Estes C, Anstee QM, Arias-Loste MT, Bantel H, Bellentani S, Caballeria J, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030. J Hepatol. 2018;69:896–904.

2. Anstee QM, Reeves HL, Kotsiliti E, Govaere O, Heikenwalder M. From NASH to HCC: current concepts and future challenges. Nat Rev Gastroenterol Hepatol. 2019;16:411–28.

3. Goldberg D, Ditah IC, Saeian K, Lalehzari M, Aronsohn A, Gorospe EC, et al. Changes in the prevalence of hepatitis C virus infection, nonalcoholic steatohepatitis, and alcoholic liver disease among patients with cirrhosis or liver failure on the waitlist for liver transplantation. Gastroenterology. 2017;152:1090–9 e1091.

4. Noureddin M, Sanyal AJ. Pathogenesis of NASH: the impact of multiple pathways. Curr Hepatol Rep. 2018;17:350–60.

5. Ju C, Tacke F. Hepatic macrophages in homeostasis and liver diseases: from pathogenesis to novel therapeutic strategies. Cell Mol Immunol. 2016;13:316–27.

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PANoptosis: a new insight for oral diseases;Molecular Biology Reports;2024-09-05

2. Intricate interplay between cell metabolism and necroptosis regulation in metabolic dysfunction-associated steatotic liver disease: A narrative review;Metabolism;2024-09

3. β-chitosan attenuates hepatic macrophage-driven inflammation and reverses aging-related cognitive impairment;iScience;2024-09

4. Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH;Cell Metabolism;2024-08

5. Deubiquitinase USP5 regulates RIPK1 driven pyroptosis in response to myocardial ischemic reperfusion injury;2024-07-10